CellaVision AB (LTS:0MR5)
kr 239.25 0 (0%) Market Cap: 5.77 Bil Enterprise Value: 5.67 Bil PE Ratio: 38.63 PB Ratio: 7.55 GF Score: 93/100

Q3 2022 CellaVision AB Earnings Call Transcript

Oct 26, 2022 / 09:00AM GMT
Release Date Price: kr243.5 (-21.89%)
Operator

Welcome to the CellaVision Audiocast with Teleconference Q3 2022. (Operator Instructions) Today, I am pleased to present CEO, Simon Ostergaard; and CFO, Magnus Blixt.

Speakers, please begin.

Simon Ostergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much, and thank you, everyone, out there listening in to hear about our third quarter highlights. I think we can get right into it. So if we take the next slide. That's perfect.

So the third quarter of this year has been a challenging quarter, and I will do my best to explain the underlying drivers behind our numbers. We did have some external challenges affecting our results. So we ended up Q3 with SEK 141 million in revenue, which represents a 7% growth. However, adjusted for currency effects, we had a negative 3%, and that is primarily due to the 10% positive contribution from the U.S. or 10% mainly from the U.S. dollar.

This results in an EBITDA of SEK 29 million, which is at 21%, which is obviously lower than our normal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot